Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.48 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3255043 | 1.00 | KMT2A (0.64) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL13848573 | 1.00 | KMT2A (0.64) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL4059785 | 0.88 | KMT2A (0.53) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL10903458 | 0.84 | KMT2A (0.50) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL7701652 | 0.84 | KMT2A (0.60) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL1521123 | 0.84 | KMT2A (0.60) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL7701655 | 0.84 | KMT2A (0.60) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL9539620 | 0.83 | ALDH1A1 (0.54) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL155984 | 0.83 | ALDH1A1 (0.54) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 | |
| SCHEMBL103235 | 0.83 | ALDH1A1 (0.54) | KMT2AALDH1A1GAAL3MBTL1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117930588-A | Photosensitive glue solution and preparation method and application thereof | 广东拓谱电子科技有限公司 | 2024-04-26 | — | — | CN | claimed |
| CN-116948543-B | Light shaping protective film for curved screen and preparation method thereof | 江西昊泽光学膜科技有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-116948543-A | Light shaping protective film for curved screen and preparation method thereof | 江西昊泽光学膜科技有限公司 | 2023-10-27 | — | — | CN | claimed |
| CN-108929226-B | Method for preparing benzoyl formate derivative | 广东工业大学 | 2021-05-28 | — | — | CN | claimed |
| CN-109096425-A | A kind of catalyst and olefine polymerizing process for olefinic polymerization | 中国石油化工股份有限公司 | 2018-12-28 | — | — | CN | claimed |
| CN-108929226-A | A method of preparing benzoyl formic acid ester derivant | 广东工业大学 | 2018-12-04 | — | — | CN | claimed |
| CN-103172511-A | Synthetic method of (R)-(-)-alpha-methoxyphenylacetic acid | UNIV SHENYANG PHARMACEUTICAL | 2013-06-26 | — | — | CN | claimed |
| EP-3541802-B1 | ALKYL SUBSTITUTED TRIAZOLE COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR | AMGEN INC (US) | 2025-01-01 | — | — | EP | disclosed |
| CN-118580164-A | Preparation method of sulfoxide derivative | 华侨大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-117930588-A | Photosensitive glue solution and preparation method and application thereof | 广东拓谱电子科技有限公司 | 2024-04-26 | — | — | CN | disclosed |
| CN-116948543-B | Light shaping protective film for curved screen and preparation method thereof | 江西昊泽光学膜科技有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-116948543-A | Light shaping protective film for curved screen and preparation method thereof | 江西昊泽光学膜科技有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116854582-A | Preparation method of enantiomerically pure alpha-methoxyphenylacetic acid | 泰州葛林美克医药科技有限公司 | 2023-10-10 | — | — | CN | disclosed |
| WO-2005014555-A1 | 4,5-DIHYDRO-IMIDAZOLE AS P2X7 ION CHANNEL BLOCKERS | AVENTIS PHARMACEUTICALS INC. (US) | 2005-02-17 | — | — | WO | disclosed |
| US-20050026916-A1 | Heterocyclic compounds as P2X7 ion channel blockers | AVENTIS PHARMACEUTICALS INC. (US) | 2005-02-03 | — | — | US | disclosed |
| WO-1998031697-A1 | ARYL C-GLYCOSIDE COMPOUNDS AND SULFATED ESTERS THEREOF | SANKYO COMPANY, LIMITED (JP) | 1998-07-23 | — | — | WO | disclosed |
| US-5389659-A | Hypotensive agents | GLAXO GROUP LIMITED (GB) | 1995-02-14 | — | — | US | disclosed |
| WO-1993005025-A1 | C-LINKED PYRAZOLE DERIVATIVES | GLAXO GROUP LIMITED (GB) | 1993-03-18 | — | — | WO | disclosed |
| US-5063225-A | Antiarrhythmia | ROUSSEL UCLAF (FR) | 1991-11-05 | — | — | US | disclosed |
| EP-0446062-A1 | C-Linked pyrazole derivatives | GLAXO GROUP LIMITED (GB) | 1991-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050026916-A1 | Heterocyclic compounds as P2X7 ion channel blockers | P2RX3, P2RX2, P2RX5 | KMT2A 3229/4885ALDH1A1 1913/4885GAA 4232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.